Omeros Corporation (OMER) vs Rapport Therapeutics, Inc. (RAPP)
- Omeros Corporation OMER 16.20 −13.78%
- Rapport Therapeutics, Inc. RAPP 27.57 −6.76%
Omeros Corporation and Rapport Therapeutics, Inc. are both Biotechnology companies. Omeros Corporation and Rapport Therapeutics, Inc. are of similar size ($1.4B and $1.4B). Rapport Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.5×. Omeros Corporation has the higher net margin (128.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Omeros Corporation leads on 7 and Rapport Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | OMER | RAPP | Biotechnology median |
|---|---|---|---|
| Gross margin | 37.57% | — | 65.16% |
| Operating margin | (74.88%) | 0.00% | 0.00% |
| Net margin | 128.36% | 0.00% | 0.00% |
| Free cash flow margin | (70.69%) | 0.00% | 0.00% |
| Return on equity | (89.15%) | (39.96%) | (56.36%) |
| Return on assets | 51.22% | (36.85%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack